News | July 23, 2008

GE’s New FDA-Cleared PET/CT Focuses on Motion

July 24, 2008 - The FDA has granted clearance for GE Healthcare’s newest positron emission tomography/computed tomography (PET/CT) scanner, which is part of GE’s Discovery family of scanners designed to enable earlier detection and monitoring of disease with advanced molecular imaging technology in both hardware and software.

The new system will be optimized for use in oncology, which represents more than 90 percent of clinical PET/CT exams. The system continues using the highest-sensitivity crystals in the industry, along with GE’s exclusive VUE Point HD, High Definition imaging to help clinicians advance towards the goal of Motion Free PET/CT imaging.

“The newest PET/CT scanners are an important step toward further reducing the effects of motion and improving the physician’s ability to help patients through better clinical images,” a company spokesperson said.

Motion generated by the patient’s respiration can blur small lesions affecting resolution and quantitative accuracy. VUE Point HD, combined with other GE-exclusive motion-management techniques help improve lesion detectability, treatment planning and quantitative accuracy, improved contrast-to-noise of moving lesions up to 60 percent versus static acquisition for overall better clinical confidence.

The company will ship the first new scanners to customers in the fourth quarter of this year.

For more information: www.gehealthcare.com

Related Content

Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Siemens Healthineers Showcases syngo Virtual Cockpit for More Flexible Workforce Management
News | Teleradiology | November 25, 2018
During the 104th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 25-30...
Bruker Introduces New High-Performance Preclinical PET/CT Si78 System
Technology | PET-CT | September 26, 2018
September 26, 2018 — Bruker recently announced the introduction of the new preclinical...
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
Philips North America and GE Healthcare Win IMV PET Imaging ServiceTrak Awards
News | PET Imaging | June 25, 2018
IMV, part of the Science and Medicine Group and a market research and business intelligence provider to the imaging...
FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems
Technology | PET-CT | June 21, 2018
Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for...
PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
Nuclear imaging scan showing very good tissue delineation. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Nuclear imaging scan showing very good tissue delineation. It offers crisp overall image quality and sharply delineates the muscle and fat planes, vertebral margins and end plates, billiary radicals, renal calyces, aortic wall and papillary muscles of the heart. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Technology | PET-CT | June 05, 2018
June 5, 2018 — The U.S.
News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...
News | Radiopharmaceuticals and Tracers | May 09, 2018
Blue Earth Diagnostics signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a specialist in...